TAL1 Hijacks MYCN Enhancer That Induces MYCN Expression and Dependence on Mevalonate Pathway in T-cell Acute Lymphoblastic Leukemia

Investigators first identified an evolutionarily conserved enhancer element controlling the MYCN oncogene that was aberrantly activated by the TAL1 complex in T cell acute lymphoblastic leukemia cells.